GSK plc Reports 3.4B Shares Outstanding Nov 30
Ticker: GLAXF · Form: 6-K · Filed: Dec 2, 2024 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Dec 2, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-capital, voting-rights, disclosure
TL;DR
GSK has 3.4B shares outstanding as of Nov 30, all admitted to trading, no treasury shares.
AI Summary
GSK plc announced its total voting rights and capital as of November 30, 2024. The company's issued share capital consists of 3,404,206,571 ordinary shares, each with a nominal value of £0.10. There are no shares held in treasury, and all issued shares are admitted to trading on the London Stock Exchange and the Official List of the Financial Conduct Authority.
Why It Matters
This disclosure provides transparency on the total number of voting shares, which is crucial for investors to understand their potential voting power and for calculating key financial metrics.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of share capital and voting rights, with no new financial or operational risks indicated.
Key Numbers
- 3,404,206,571 — Total Voting Shares (Issued ordinary shares as of November 30, 2024, all admitted to trading.)
- £0.10 — Nominal Value per Share (The nominal value of each of the company's ordinary shares.)
Key Players & Entities
- GSK plc (company) — Registrant
- 3,404,206,571 (dollar_amount) — Issued ordinary shares as of November 30, 2024
- £0.10 (dollar_amount) — Nominal value per ordinary share
FAQ
What is the total number of issued ordinary shares of GSK plc as of November 30, 2024?
As of November 30, 2024, GSK plc had 3,404,206,571 issued ordinary shares.
Does GSK plc hold any shares in treasury?
No, the filing states that there are no shares held in treasury.
What is the nominal value of each ordinary share of GSK plc?
Each ordinary share of GSK plc has a nominal value of £0.10.
Where are GSK plc's ordinary shares admitted to trading?
All issued ordinary shares are admitted to trading on the London Stock Exchange and the Official List of the Financial Conduct Authority.
What is the purpose of this 6-K filing?
This 6-K filing notifies the market of the company's total voting rights and capital in conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R.
Filing Stats: 324 words · 1 min read · ~1 pages · Grade level 11.9 · Accepted 2024-12-02 11:12:31
Filing Documents
- a4573o.htm (6-K) — 16KB
- 0001654954-24-015058.txt ( ) — 17KB
SIGNATURES
SIGNATURES     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.   GSK plc   (Registrant)     Date: December 02, 2024         By:/s/ VICTORIA WHYTE --------------------------       Victoria Whyte   Authorised Signatory for and on   behalf of GSK plc